Skip to Main Content

Paper Details

Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models.
Pharmacol Res
3
2023
Author NameAffiliation
Jason E GestwickiDepartment of Pharmaceutical Chemistry, University of California san francisco
Christopher P EvansUniversity of California, USA University of California, Davis Comprehensive Cancer Center
  • 1 - 2

Datasets

Release 1.2